Your browser doesn't support javascript.
loading
Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma.
Sada, Ikuyo; Harada, Yosuke; Hiyama, Tomona; Mizukami, Mina; Kan, Takanobu; Kawai, Mikio; Kiuchi, Yoshiaki.
Afiliación
  • Sada I; Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University.
  • Harada Y; Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University.
  • Hiyama T; Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University.
  • Mizukami M; Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University.
  • Kan T; Department of Dermatology, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Kawai M; Department of Dermatology, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.
  • Kiuchi Y; Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University.
Melanoma Res ; 33(6): 539-546, 2023 12 01.
Article en En | MEDLINE | ID: mdl-37788106
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_malignant_skin_melanoma / 6_skin_diseases Asunto principal: Neoplasias Cutáneas / Uveítis / Melanoma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_malignant_skin_melanoma / 6_skin_diseases Asunto principal: Neoplasias Cutáneas / Uveítis / Melanoma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article